Showing 1 - 4 results of 4 for search 'Jinxi Ding', query time: 0.02s Refine Results
  1. 1
    Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned survival model

    Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned surv... by Gang Fang, Zhipeng Pi, Yiping An, Xinxin Cao, Wei Li, Wei Li, Xiangjun Zhu, Jinxi Ding, Jinxi Ding

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Cost-utility of aripiprazole once-monthly versus paliperidone palmitate once-monthly injectable for schizophrenia in China.

    Cost-utility of aripiprazole once-monthly versus paliperidone palmitate once-monthly injectable for schizophrenia in China. by Yiping An, Gang Fang, Zhipeng Pi, Yumeng Zhang, Wei Li, Jinxi Ding

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Cost-utility of aripiprazole once-monthly versus paliperidone palmitate once-monthly injectable for schizophrenia in China

    Cost-utility of aripiprazole once-monthly versus paliperidone palmitate once-monthly injectable for schizophrenia in China by Yiping An, Gang Fang, Zhipeng Pi, Yumeng Zhang, Wei Li, Jinxi Ding

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Changes in antibiotic use associated with the National Centralized Drug Procurement policy in China from 2019 to 2023

    Changes in antibiotic use associated with the National Centralized Drug Procurement policy in China from 2019 to 2023 by Fanyu Lin, Haoye Li, Siyuan Yao, Nannan Zhao, Keying Zhu, Jinxi Ding, Wei Li

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: